Soluble platelet selectin and platelets in COVID-19: a multifaceted connection

Emmanuel Ifeanyi Obeagu1, Getrude Uzoma Obeagu2, Patrick Maduabuchi Aja3,4

  • 1Department of Medical Laboratory Science, Kampala International University.

Insights

Platelets and soluble P-selectin (sP-selectin) are key in COVID-19 immunothrombosis. Targeting these may reduce thromboinflammation and improve patient outcomes.

Area of Science:

  • Immunology
  • Hematology
  • Vascular Biology

Background:

  • Platelets play a critical role in hemostasis and have emerged as significant contributors to immunothrombotic complications in COVID-19.
  • Elevated soluble P-selectin (sP-selectin) levels, indicating platelet activation and endothelial injury, are consistently observed in COVID-19 patients.
  • These markers correlate with disease severity and adverse outcomes, highlighting their prognostic value.

Purpose of the Study:

  • To elucidate the intricate relationship between platelets, sP-selectin, and COVID-19 pathogenesis.
  • To understand the role of platelet activation in amplifying systemic inflammation and endothelial injury.
  • To explore the potential of targeting platelet-mediated pathways for therapeutic interventions.

Main Methods:

  • Observational studies analyzing platelet activation markers and sP-selectin levels in COVID-19 patients.
  • Analysis of correlations between marker levels, disease severity, and clinical outcomes.
  • Review of existing literature on platelet function and thromboinflammation in viral infections.

Main Results:

  • Platelet activation contributes to the release of inflammatory mediators and platelet-leukocyte interactions, worsening systemic inflammation and endothelial damage.
  • Platelet-derived factors promote microvascular thrombosis, exacerbating tissue damage and organ dysfunction in severe COVID-19.
  • Elevated sP-selectin serves as a biomarker for disease severity and aids in risk stratification.

Conclusions:

  • Platelets and sP-selectin are pivotal in orchestrating thromboinflammation, vascular dysfunction, and disease progression in COVID-19.
  • Therapeutic strategies targeting platelet activation and sP-selectin pathways, including antiplatelet and anti-inflammatory agents, show promise.
  • A deeper understanding facilitates tailored treatments to mitigate thromboinflammation and improve COVID-19 patient outcomes.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
502
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657